When a stock loses 20% of its value in a single day, you're either witnessing a company in serious trouble or watching the market have a bit of a panic attack. Cantor Fitzgerald is betting on the latter with UnitedHealth Group Inc. (UNH).
The healthcare giant took a beating Tuesday after serving up a disappointing 2027 Medicare Advantage Advance Notice alongside fourth quarter earnings that technically met profit expectations but came with an unwelcome surprise: a rare revenue decline projected for the coming year. Not exactly the kind of guidance that inspires confidence.
The Bull Case Amid the Wreckage
While other analysts were busy slashing price targets, Cantor held firm with its Overweight rating and $440 price target on UnitedHealth. That's a bold move when everyone else is heading for the exits.
Here's why they're not panicking. First, Cantor figures more than half of Tuesday's carnage stems from anxiety over those 2027 Medicare Advantage rates. The firm believes UnitedHealth can navigate unfavorable rates through smarter pricing strategies and margin-focused bidding. In other words, management has levers to pull.
Second, there's the matter of 2026 earnings guidance. Nobody's expecting an overnight miracle recovery, but Cantor thinks investor sentiment will improve as people gain confidence in the company's projected adjusted EPS of $17.86 for 2026. The path there involves margin expansion across multiple business segments.
The UnitedHealthcare division alone should contribute roughly 86 cents to the EPS bridge, driven by a recovery in Commercial margins and steady Medicare Advantage margin growth. Meanwhile, Optum Health is getting back to basics, which Cantor expects will add another 24 cents to that 2026 EPS story.
The Bottom Line
Cantor's maintaining its bullish stance reflects confidence in UnitedHealth Group's fundamental strength. Yes, challenges remain, from elevated medical costs to regulatory headwinds. But the firm sees the current price as an attractive entry point for patient investors willing to hold through 2026.
The market seemed to agree slightly on Wednesday, with shares climbing 3.86% to $293.62. That's hardly a victory lap, but it's a start.
